Günther Krumpl

Title: The Innovations of Günther Krumpl

Introduction

Günther Krumpl is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of medicine, particularly in the treatment of tachyarrhythmias. His innovative approach has led to advancements that benefit patients suffering from heart-related conditions.

Latest Patents

Günther Krumpl holds a patent for the "Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias." This invention provides a new application of landiolol hydrochloride for the persistent reduction of heart rate during treatment. The method involves administering landiolol hydrochloride at a constant dose of more than 5 µg/kg/min, specifically at least 10 µg/kg/min for a minimum of 2 hours. This approach ensures that the heart rate and/or blood pressure of the patient are consistently reduced during the administration period, without any overshooting effect after the treatment ends. He has 1 patent to his name.

Career Highlights

Throughout his career, Günther Krumpl has worked with various pharmaceutical companies. Notably, he has been associated with AOP Orphan Pharmaceuticals AG and AOP Orphan Pharmaceuticals GmbH. His work in these organizations has contributed to the development of innovative treatments for rare diseases.

Collaborations

Due to space constraints, the details of his collaborations will not be included.

Conclusion

Günther Krumpl's contributions to medical innovation, particularly in the treatment of tachyarrhythmias, highlight his role as a significant inventor in the field. His patent for the use of landiolol hydrochloride demonstrates his commitment to improving patient care and advancing medical science.